Thursday, February 9, 2023

Why Indian pharma companies need to maintain quality to avoid Uzbekistan-like cases

The tragedy in Uzbekistan will once again bring the methods of drug manufacturing in India into the limelight. Being the third largest producer of pharmaceuticals, India is known as the ‘Pharmacy of the World’.

Pharma company embroiled in controversies due to cough syrup

Jahangir Ali: after gambia Uzbekistan Allegedly ‘Made in India’ anti-cough syrup There is news of death of 18 children after taking it. This has given another blow to the country’s pharmaceutical industry. These deaths have been reported in the city of Samarkand. Where to Cure “Cold & Flu Symptoms” in Noida Marion Biotech Of the 21 children with respiratory illnesses, 18 died after consuming Dr-1 Max syrup manufactured by Dr.

Download Link

A few months ago, at least 69 children were reported dead in The Gambia after exposure to four cough medicines – Cofexmaline, Promethazine Oral Solution, Makof and Magrip N –. These medicines were made by Haryana-based Maiden Pharmaceuticals Limited.

India is known as the ‘Pharmacy of the World’

The tragedy in Uzbekistan will once again bring the methods of drug manufacturing in India into the limelight. Being the third largest producer of pharmaceuticals, India is known as the ‘Pharmacy of the World’. India has also helped developed countries like the US and the UK to reduce healthcare costs.

Lax regulations and poor government oversight are blamed for the spread of substandard construction practices in the country. According to the Central Drug Standard Control Organisation, the official drug regulatory authority in India, about 4.5 per cent of drugs in the Indian market are of substandard quality.

A World Health Organization survey found that one in ten drugs exported by India to middle- and low-income countries was substandard.

please explain more

The ever-increasing global demand for drugs often affects the balance between supply and demand for the raw materials used in drug manufacturing. Lax quality control and lax regulations at manufacturing sites result in poor quality of the final product.

Authorities in Uzbekistan and the Gambia have claimed that the deaths of children have been linked to the presence of ‘toxic’ substances—diethylene glycol and ethylene glycol—in cough syrups. A UN investigation in The Gambia found “unacceptable amounts” of these substances in the syrup. However, India denied these claims.

Companies are using substandard raw material to reduce the cost. Mass poisoning from cough syrup is not a new phenomenon. Since the 1990s, similar incidents have occurred in China, Argentina, Panama, and other countries as the glycerin used in cough syrups has been replaced by ethylene and diethylene glycol, which are cheaper substitutes and can save lives. can prove to be dangerous.

Why is this so important?

India’s pharma industry is worth 50 billion dollars. India’s share in the global pharmaceutical market is about 6 percent. Pharmaceuticals and drugs worth $24.62 billion were exported during 2021-22, up 18 per cent from the previous year.

The incident in Gambia has not only raised questions about the manufacturing practices of the drug but also dented India’s reputation as one of the leading drug manufacturing countries in the world. If this continues, low and middle income countries, which depend on India for cheap medicines, will look for alternatives elsewhere.

the twist

Cough syrups are not for sale over-the-counter. These medicines should be given by the doctor. However, according to Uzbekistan’s Ministry of Health, 18 of the deceased children had taken this syrup at home for two to seven days, sometimes in excess of the prescribed dose, without a doctor’s prescription.

India has denied the presence of diethylene glycol and ethylene glycol in four cough syrups blamed for the deaths of 69 children in Gambia, contradicting the findings of a UN probe. In such a situation, it is unlikely that any action will be taken against Noida-based Marion Biotech.

(Disclaimer: The views expressed in this article are those of the author. The views and facts given in this article do not represent the stand of News9.)

spot_imgspot_img
spot_img

Hot Topics

Related Articles